A carregar...
Proteasome Inhibitors: Structure and Function
Since 2003, with the FDA approval of bortezomib, proteasome inhibitors have changed the management of hematologic malignancies and dramatically improved outcomes for patients with multiple myeloma and mantle cell lymphoma. Since that time, two additional proteasome inhibitors, carfilzomib and ixazom...
Na minha lista:
| Publicado no: | Semin Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6020165/ https://ncbi.nlm.nih.gov/pubmed/29935898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2018.01.004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|